Burden of upper gastrointestinal cancers in the east of Golestan province (Golestan cohort study)

Author:

Jahani Mohammad‐Ali1,Esmaeili Raziyeh2,Abbasi Mahdi3ORCID,Nikbakht Hossein‐Ali1,Azarbakhsh Habibollah4ORCID,Roshandel Gholamreza5,Delavari Sahar6,Shojaie Layla7,Mahmoudi Ghahraman8

Affiliation:

1. Social Determinants of Health Research Center Health Research Institute, Babol University of Medical Sciences Babol Iran

2. Health Services Management Golestan University of Medical Sciences Gorgan Iran

3. Department of Health Economics and Management School of Public Health, Tehran University of Medical Sciences Tehran Iran

4. Student Research Committee Shiraz University of Medical Sciences Shiraz Iran

5. Golestan Research Center of Gastroenterology and Hepatology Golestan University of Medical Sciences Gorgan Iran

6. Institute for the Developing Mind, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California Los Angeles California USA

7. Division of GI/Liver, Department of Medicine Keck school of Medicine, University of Southern California Los Angeles California USA

8. Hospital administration Research Center, Sari Branch, Islamic Azad University Sari Iran

Abstract

AbstractBackgroundCancers, especially Upper Gastrointestinal Cancers (UGCs), pose a substantial burden on society, particularly in developing nations. Golestan province, Iran, is known for its high UGC rates globally.AimsThis study delves into the disease burden of UGCs in the eastern part of Golestan province.Methods and ResultsThis study was conducted using the results of the Golestan cohort study. 2711 patients participating in this cohort, who visited Atrak Clinic during 2001–2020, participated in this study. After excluding patients with incomplete records, 2481 patients were included in the study. To compute the metrics of years of life lost (YLL), years of life lived with disability (YLD), and disability‐adjusted life years (DALY), we utilized the World Health Organization's standard life table, stratified by age and gender. The majority of UGC patients in our study were married (81.8%), had limited formal education (82.6%), and were predominantly male (61.1%). A substantial proportion resided in suburban areas (85.8%), and over half of the patients (52%) reported a history of drug addiction. The mean age at diagnosis for men was 65.76 years with a standard deviation of 11.34, while for women, it was 64.38 years with a standard deviation of 11.66. Regarding disease impact, YLL, YLD, and DALY for men were 21 240, 1956, and 23 196 (307.8 per 100 000), respectively. For women, these figures were 15 609 for YLL, 1367 for YLD, and 16 976 (223.1 per 100 000) for DALY.ConclusionAfter the increasing trend of the burden of UGCs in Golestan province in the early years of the study, this rate has been decreasing in recent years. Effective strategies necessitate collaborative efforts across various sectors to alleviate this burden, focusing on preventive measures, timely diagnosis, and well‐coordinated therapeutic interventions.

Publisher

Wiley

Reference38 articles.

1. A Global Cancer Surveillance Framework Within Noncommunicable Disease Surveillance: Making the Case for Population-Based Cancer Registries

2. The increasing prevalence of non-communicable diseases in low-middle income countries: the view from Malawi

3. Cancer incidence, mortality, years of life lost, years lived with disability, and disability‐adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019;Global burden of disease 2019 cancer collaboration;AMA Oncol,2021

4. Scaling up action on the prevention and control of noncommunicable diseases in the WHO Eastern Mediterranean Region

5. The integration and management of noncommunicable diseases in primary health care

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3